SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001829126-21-008080
Filing Date
2021-08-16
Accepted
2021-08-16 16:40:01
Documents
53
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q inspyr_10q.htm   iXBRL 10-Q 952248
2 EXHIBIT 31.1 inspyr_ex31-1.htm EX-31.1 7631
3 EXHIBIT 31.2 inspyr_ex31-2.htm EX-31.2 7751
4 EXHIBIT 32.1 inspyr_ex32-1.htm EX-32.1 5149
5 EXHIBIT 32.2 inspyr_ex32-2.htm EX-32.2 5357
  Complete submission text file 0001829126-21-008080.txt   3624105

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE nspx-20210630.xsd EX-101.SCH 28584
7 XBRL CALCULATION FILE nspx-20210630_cal.xml EX-101.CAL 31214
8 XBRL DEFINITION FILE nspx-20210630_def.xml EX-101.DEF 99860
9 XBRL LABEL FILE nspx-20210630_lab.xml EX-101.LAB 212404
10 XBRL PRESENTATION FILE nspx-20210630_pre.xml EX-101.PRE 171188
11 EXTRACTED XBRL INSTANCE DOCUMENT inspyr_10q_htm.xml XML 421163
Mailing Address 2629 TOWNSGATE RD, SUITE 215 WESTLAKE VILLAGE CA 91361
Business Address 2629 TOWNSGATE RD, SUITE 215 WESTLAKE VILLAGE CA 91361 (210) 479-8112
Inspyr Therapeutics, Inc. (Filer) CIK: 0001421204 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55331 | Film No.: 211179091
SIC: 2834 Pharmaceutical Preparations